Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001094891-21-000243
Filing Date
2021-06-04
Accepted
2021-06-04 09:40:44
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 3325
  Complete submission text file 0001094891-21-000243.txt   5111
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DAVID NUSSBAUM EARLYBIRDCAPITAL, INC 366 MADISON AVE, 8TH FL NEW YORK NY 10017
Business Address C/O DAVID NUSSBAUM EARLYBIRDCAPITAL, INC 366 MADISON AVE, 8TH FL NEW YORK NY 10017 2126610200
BRAC Lending Group LLC (Reporting) CIK: 0001759828 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-38302 | Film No.: 21995189